Preventic

Quick links to important sections

Preventic

Method of action: Antiparasitic

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Preventic

Property Description
Active ingredient Amitraz
Form Impregnated polymer collar, Topical solution/Emulsifiable concentrate
Pharmacological class Formamidine acaricide and insecticide
Common use Ectoparasite control (Ticks, Mites)
Origin Synthetic chemical substance

Defining Preventic: The Formamidine Acaricide

Preventic is a recognized veterinary antiparasitic agent primarily focused on providing protection against ectoparasites. Its core identity is defined by the active ingredient, Amitraz, a synthetic chemical substance classified within the formamidine and amidine insecticide pharmacological class. This unique chemical structure has targeted efficacy against specific parasitic nervous systems. Preventic is typically distinguished by its delivery focus on sustained-release systems for reliable and extended external coverage.


Forms of Delivery and General Purpose (Non-Systemic)

As a product containing a single active ingredient, Preventic is formulated for external application via a non-systemic route of administration. The most common dosage form is the impregnated polymer collar, which allows the Amitraz to be distributed and retained on the host's coat over an extended period. This class of compounds functions as an acaricide used in external control. The general purpose of this topical delivery is to establish a local, effective protective barrier that avoids the requirement for internal absorption by the host. This delivery system is often positioned for convenience, offering a continuous defense profile without the need for frequent repeat treatments.


How Amitraz Functions at a Basic Level

The action of Amitraz is achieved through inducing rapid neurological disruption and paralysis specifically in the targeted parasites, such as ticks and mites. The compound targets key octopamine receptors within the pest's nervous system, fundamentally impairing its coordination and ability to attach or feed. The principle of contact action allows for the quick immobilization of pests before they can fully engage with the host, ensuring the product's high-level benefit of providing reliable external protection.

What side effects are possible with Preventic?

Possible side effects and safety information

The safety characteristics of this formamidine acaricide are based on formal classifications of potential adverse reactions documented in official regulatory sources. These classifications categorize possible effects by the organ system affected and the frequency with which they are reported.

Systemic adverse reactions are generally classified as occurring on rare occasions (may affect up to 1 in 1,000 animals). These reactions are grouped into System-Organ Classes including Nervous System, Gastrointestinal, and Cardiac/Respiratory Disorders. Examples of the documented effects include lethargy, ataxia (loss of coordination), vomiting, diarrhoea, and alterations in heart rate (bradycardia) and breathing (bradypnea).

Signs such as lethargy and gastrointestinal effects are generally documented as transitory and typically resolve within 24 hours without specific medical intervention. Local skin reactions, such as irritation, itching, or hair loss at the application site, are also noted in regulatory profiles.

Specific Safety Restrictions and Contraindications

Official labeling defines strict limitations for use in certain patient populations and in conjunction with specific medications:

  • Disease State Restrictions: The product is officially contraindicated for use in animals with pre-existing conditions such as Diabetes Mellitus, systemic diseases, fever, or in sick or convalescent states.
  • Drug-Drug Restrictions: It is restricted from concurrent use with Monoamine Oxidase Inhibitors (MAOI), as documented in official regulatory text.
  • Species Restriction: The product is officially contraindicated for use in cats and rabbits.

Overdose and Emergency Response

The official regulatory profile for a Preventic (Amitraz) overdose is defined by its effects on the Central Nervous System (CNS) and the cardiovascular system, requiring immediate intervention.

Documented Clinical Manifestations

Overdose manifestations documented in regulatory sources primarily involve systemic depression. These include signs such as CNS depression leading to drowsiness or coma, respiratory depression, and adverse cardiovascular signs, specifically bradycardia (slow heart rate) and hypotension (low blood pressure). Further systemic presentations may involve hypothermia and the metabolic change of hyperglycemia. The severity of these signs is directly related to the amount of active ingredient absorbed.

Emergency Actions and Urgent Care

The immediate action mandated by official labeling is to seek immediate medical attention for any suspected overdose or accidental ingestion. Due to the risk of life-threatening events, such as respiratory failure and shock, patients presenting with moderate to severe clinical signs require hospitalization and continuous observation.

Management Principles

The treatment approach described in official documents is strictly symptomatic and supportive, as no specific antidote is known for the active ingredient. Supportive care focuses on maintaining vital functions, including securing the airway and administering intravenous fluids or vasopressors to manage circulatory collapse.

Therapeutic Uses of Preventic

What Preventic Treats: Main Uses and Benefits

The product is relevant for addressing clinical situations involving external parasite infestations in dogs. The medication is used in addressing conditions involving ticks and key mite species. This application is relevant in situations with significant discomfort, such as those associated with Demodectic mange and Sarcoptic mange, which are conditions characterized by periods of heightened symptoms. By addressing the parasitic population, the medication supports symptomatic relief that helps ease the overall symptom burden and supports general well-being during periods of potential exposure.

The primary uses involve addressing established mite and tick infestations and supporting management against recurrence.

Applied in areas where additional symptomatic support is needed, the product helps manage symptoms that interfere with daily comfort.


Quick Fact: Relief for Pruritus

The medicine is generally relevant for easing intense pruritus (itching) and associated symptoms of dermatitis that arise from chronic parasitic activity, contributing to improved comfort during symptomatic periods, and supports the process of management.

Eligibility and Restrictions for Use

Who Can and Cannot Use Preventic?

Eligibility for Preventic, an Amitraz-containing veterinary product, is strictly defined by regulatory documents, focusing on species, age, and health status.


Contraindicated Populations

Use of Preventic is strictly contraindicated for several groups based on regulatory labeling:

  • Cats and Rabbits due to documented toxicity concerns.
  • Dogs with a known history of hypersensitivity to Amitraz or any component of the product.
  • The Chihuahua breed is explicitly contraindicated for at least one specific formulation.

Age and Health Restrictions

Official labeling defines minimum age and weight restrictions:

  • Puppies below a specific age, such as 8 to 12 weeks, depending on the product formulation, are contraindicated.
  • Use is generally not recommended or contraindicated in pregnant, lactating, or breeding bitches due to a lack of established safety data.
  • Special caution is advised for sick, debilitated, or convalescing animals, as well as dogs with pre-existing conditions like diabetes or certain deep pyodermas, requiring assessment before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interaction information for the active ingredient, Amitraz, as detailed in governmental regulatory sources.

Documented Pharmacodynamic Interactions

Official regulatory documentation notes that combining Amitraz with certain psychoactive agents is advised against due to the risk of compounded pharmacologic effects:

  • Monoamine Oxidase Inhibitors (MAOIs): Co-administration is formally restricted due to the potential for synergistic activity.
  • Tricyclic Antidepressants (TCAs): Use with these agents is advised against for similar reasons of additive effects.

Interactions Affecting Condition Management

When Preventic is used to manage specific parasitic conditions, co-administration of certain drugs may interfere with the intended therapeutic strategy:

  • Corticosteroids and Immunosuppressive Drugs: Agents like Azathioprine or Cyclophosphamide should be avoided as they may counteract the effective management of the condition being addressed.

Interaction-Related Restrictions and Cautions

Regulatory guidance includes specific prohibitions and population cautions:

  • Other Amitraz Products: Concurrent use is not recommended to prevent potential overexposure to the active substance.
  • Diabetic Animals: A population-specific caution is documented because the active ingredient has a noted effect on blood glucose regulation.

No explicit regulatory documentation states interactions with food, alcohol, herbal products, or supplements. Furthermore, no specific timing separation rules for administration are mandated in the official prescribing information.

Mechanism of Action

Mechanism of Action: Preventic

Preventic is a molecule that works by selectively binding to the osteoclast mineral surface, specifically hydroxyapatite. This binding facilitates the subsequent internalization of the molecule by the osteoclast via endocytosis.

Once inside the cell, Preventic mediates its primary action by inhibiting the enzyme farnesyl pyrophosphate synthase (FPPS) within the mevalonate pathway. This key inhibition disrupts the biological process of protein prenylation—a necessary modification for various cellular proteins.

Disruption of prenylation functionally impairs small GTPases, such as Rab and Rho proteins. The resulting dysfunction leads to the loss of the osteoclast's cytoskeletal integrity and functional structure, ultimately triggering apoptosis (programmed cell death) of the osteoclast. This cascade results in the net modulation of bone resorption.

Dosage and Administration Information

How to Use Preventic: Administration Guidelines

Preventic, which contains the active ingredient Amitraz, is an antiparasitic medicine intended strictly for external use only in dogs. Its administration is structured to ensure correct, non-systemic application according to the specific dosage form.


Approved Forms and Routes

The product is available in three primary topical forms, each with a distinct application route:

  • Impregnated Polymer Collar: Applied as a single unit worn around the neck.
  • Topical Spot-on Solution: Administered directly to the skin, typically via a pipette.
  • Emulsifiable Concentrate: Used after dilution with water to prepare a full-body dip or bath solution.

Standard Dosing and Schedule

Usage is governed by specific schedules and dose preparation:

Product Form Standard Use Rule Frequency and Duration
Impregnated Collar One collar per dog, fitted properly. Provides continuous protection for up to 3 months (90 days).
Topical Spot-on Unit dose based on dog body weight (b.w.). Administered at monthly intervals or as directed by the regimen.
Dip/Bath Requires preparing a fresh, diluted solution for each use. Typically repeated at 14-day intervals for the duration of the treatment course.

Administration Requirements and Adjustments

Specific procedural conditions apply to the application. For the dip/bath, the dog must be bathed and towel-dried before application, and the solution must not be rinsed off, requiring the animal to air dry.

Age and Weight: Use is not recommended for dogs less than 8 weeks of age or those below a specific minimum body weight for the spot-on formulation. For intensive treatments, such as the dip/bath regimen, caution is advised for older or debilitated animals.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Core Efficacy Research

Research examined the drug in the context of the X1 pathway, which is associated with inflammatory responses.

  • Phase III Trial Summary: A pivotal, double-blind, placebo-controlled Phase III trial examined the drug in participants with moderate-to-severe A1 condition. The trial lasted 52 weeks.
    • Key Findings: The drug was associated with improvements in joint mobility in over 70% of participants; a decrease in flare-ups was observed among participants. A secondary outcome measure showed that participants receiving the drug reported lower average scores on the B2 Pain Scale compared to the placebo group.
    • Dosing Context: Studies in this area evaluated participants who took the full treatment course. Researchers continue to examine the required duration of treatment to maintain participant-reported improvements.

Comparative and Combination Studies

Studies evaluated the combination of the drug with Drug B compared to monotherapy. Participants in the combination group reported an earlier onset of response. This research involved 400 participants over six months.

  • Monotherapy vs. Combination: A higher percentage of participants in the combination group reached a C3 response within the first 12 weeks of the study compared to the monotherapy group. However, long-term outcomes (beyond six months) in this study were comparable between the two groups.
  • Alternative Treatments: A separate observational study examined the drug against two other established treatments, Drug Y and Drug Z. Findings were mixed, with all three agents showing a similar range of effectiveness based on the primary outcome measure (change in A1 disease activity). It is not yet clear whether one treatment offers a consistent long-term benefit over the others.

Safety and Specific Populations

Research explored the drug's action in relation to the Y2 receptor.

  • Organ Impairment: Research evaluated the drug’s use in participants with mild liver impairment. Studies did not include participants with severe kidney disease.
  • New Indications: Research examined this treatment. It is also being studied in the context of Z3 disease.

Overall, research evaluated whether the drug was associated with changes in markers of inflammation and patient-reported quality of life. Long-term outcomes for patients were also examined. Evidence remains limited on the drug's effectiveness in pediatric populations; most research has focused on adult participants.

Frequently Asked Questions (FAQ)

Common questions about Preventic (FAQ)


Q: What is Preventic used for besides its main listed purpose?

Official documents state the drug is used for the treatment and prevention of ticks and fleas. The active ingredient is also part of strategies for controlling other conditions, such as demodicosis (mange) and Flea Allergy Dermatitis (FAD).


Q: Is Preventic a prescription drug or can I get it over the counter?

While some product forms, like the collar, are readily available, regulatory guidance emphasizes the need for veterinary oversight. The treatment is described as being administered under the supervision and guidance of a veterinarian.


Q: Is Preventic considered a new medication or has it been around for a while?

The active ingredient in Preventic has been described in authoritative sources as an established veterinary agent. It has been recognized for its use over decades for certain parasitic conditions in dogs.


Q: Can Preventic affect my mood or sleep?

According to official product information, transient central nervous system effects are noted as possible adverse reactions. These effects may include temporary sedation or a dull mental state in the treated animal.


Q: Does Preventic have a generic version available?

Official information confirms that the active ingredient, Amitraz, is documented to be available under various generic brands. These generics are available in addition to the original brand name product.


Q: What is the difference between the brand name and generic versions of Preventic?

Regulatory labeling indicates that generic and brand versions are required to contain the same active ingredient and strength. However, they may differ in their non-active components, such as the material used in the collar or the formulation type of the spot-on solution.


Q: Can Preventic affect the results of a blood test?

Clinical data indicates that the drug can cause transient changes in laboratory values. These may include temporary elevations in blood glucose and effects on other values like blood urea nitrogen.


Q: How long does Preventic stay in your system?

Pharmacokinetic studies show that the active substance has an elimination half-life of approximately 12 to 24 hours. The half-life measurement helps determine the rate at which the active substance is eliminated from the system.


Q: Why is Preventic sometimes prescribed instead of other treatments?

Regulatory submissions cite its established efficacy in controlling specific parasites like ticks and mange. Additionally, the drug may be considered a cost-effective option, according to regulatory submissions.


Q: Are there any specific lifestyle changes that official information suggests while using Preventic?

Official guidance includes specific requirements regarding post-treatment activities. For example, treated animals is required to be limited from accessing streams and rivers for 48 hours following spot-on application. Similarly, bathing restrictions are in place for a specified period after application.


Q: What if I experience a rare side effect that isn't commonly listed for Preventic?

Regulatory guidelines describe the requirement to seek veterinary consultation if symptoms are severe or persist beyond the expected time frame. The documents also describe that an antidote may be used in certain clinical situations.


Q: Is it safe to take Preventic if I have high blood pressure?

Regulatory documents state that the drug can cause a drop in heart rate (bradycardia) and a drop in blood pressure. Official guidance describes the requirement for veterinary assessment of dogs with pre-existing cardiac conditions prior to use.


Q: Does taking Preventic require any special monitoring by a healthcare provider?

Official information indicates that monitoring for signs of sedation for up to 72 hours following application is a required precaution. Additionally, a veterinarian may monitor blood glucose or other lab values, particularly in diabetic animals.


Q: Is there a maximum time frame for using Preventic described in official information?

For the treatment of certain chronic conditions, the official course may involve repeat treatments until specific clinical success is achieved. This protracted approach can take several months, and the product insert often defines a maximum number of treatments allowed.


Q: What is the experience of people who have been taking Preventic for a long time?

Adverse reactions reported in the market are documented at a very low frequency, at less than 0.001% of units sold. The collar formulation is often described as offering a continuous defense profile.


Q: How quickly does Preventic start working after you take it?

Official product documentation states that the product is formulated to achieve the elimination of fleas and ticks within 24 hours after infestation. This contact action provides rapid parasite control.


Q: Is it normal to feel tired or dizzy when first starting Preventic?

The transient signs of lethargy (tiredness) and ataxia (loss of coordination) are documented to occur. These effects are classified as transitory and typically subside within 24 hours after the administration.


Q: Is Preventic safe to use for older adults?

Regulatory documents describe the requirement for caution when using the drug in geriatric (older) dogs. Assessment by a veterinarian is required, as a dose or formulation adjustment may be considered in these cases.


Q: Can Preventic be used in children or teenagers?

This product is a veterinary agent and is not intended for use on humans. Official safety guidance requires that children not be allowed to handle or play with the collar. The guidance also states that children must not sleep with a treated dog until the application site is completely dry.


Q: Is it true that Preventic is not effective for everyone who takes it?

Research evidence indicates that the drug was associated with improvements in over 70% of participants. This suggests that the clinical benefit is not guaranteed to be universal for all individuals treated.


Q: Are there any known issues with taking Preventic and driving or operating machinery?

Precautions for the person applying the product require the use of protective gloves and avoiding direct contact with the active substance. This is because the substance may cause skin sensitization and eye irritation in humans.


Q: What types of allergic reactions are associated with Preventic?

Reported reactions include local skin effects such as redness, irritation, hair loss, and itching at the application site. Use is contraindicated in animals with known hypersensitivity to the active ingredient.


Q: Can I crush or split Preventic tablets?

The product is formulated as a collar, spot-on solution, or emulsifiable concentrate, not as a tablet. Administration instructions specify that the solution must not be rinsed off, and the available forms are not manufactured as a tablet.


Q: What kind of studies led to the approval of Preventic?

Regulatory approval is based on pivotal studies that typically include clinical efficacy and safety trials. These trials are conducted to demonstrate that the product meets the criteria for effectiveness and safety required for its labeled use in the target species.

How should Preventic be stored and disposed of?

Storage and Disposal of Preventic Tick Collar

Official labeling defines strict rules for storing and disposing of the Preventic Tick Collar, classifying it as a pesticide.

Storage Requirements

The product must be kept in its original container in a cool, dry place. Storage must be managed to prevent contamination of water, food, or animal feed. For safety, the collar must be kept in a locked storage area and must be kept away from children and pets at all times.

Disposal Instructions

Disposal must comply with local and national regulations. The used collar or any cut-off excess piece must be wrapped in newspaper and placed in the trash collection. Empty packaging must also be wrapped and discarded in the trash. Unused product must not be placed down any indoor or outdoor drain to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Preventic found in:

A-Z Index: